The slip
PARKINSON RECEIPTno. 11093
26 Oct 2026, 18:25 UTCdopamine neurons, braak
predictionGNAI2 in dopamine neurons tracks Braak Lewy-body stage
registered33a57c03d78df378
discovery-0.37 p=0.329 n=9
replication-0.56 p=0.118 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.37, p 0.329)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe96a333b514b7fa2ebf06ad8…
follows fdc01bd7bd4b…
Covered by the on-chain checkpoint of receipt 11102 (2026-10-26 18:39 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11093: GNAI2 in dopamine neurons, braak
- power
- full sample -0.52 (p 0.026, n 18), 95% CI -0.80 to -0.07. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.52 (p 0.027, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.60 (p 0.0086, n 18). not the mix.
- skeptic
- leave-one-out range -0.64 to -0.46, sign flips 0; without severely affected donors -0.52 (p 0.026, n 18). robust.
- cell type
- strongest in OPCs: -0.60 (p 0.0080, n 18) vs -0.52 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GNAI2 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up GNAI2 · OPCs · braak: substantia nigra, an independent cohort: not measured